Candida isolates causing refractory or recurrent oropharyngeal candidiasis in 11 hospitals in China

References

• Brito GN, Inocencio AC, Querido SM, Jorge AO, Koga-Ito CY. In vitro antifungal susceptibility of Candida spp. oral isolates from HIV-positive patients and control individuals. Braz Oral Res. 2011;25(1):28–33.21271179
   PubMed Web of Science ®Google Scholar
• Moges B, Bitew A, Shewaamare A. Spectrum and the in vitro antifungal susceptibility pattern of yeast isolates in Ethiopian HIV patients with oropharyngeal candidiasis. Int J Microbiol. 2016;2016:3037817. doi:10.1155/2016/303781726880925
   PubMedGoogle Scholar
• Sun H, Chen Y, Zou X, et al. Occurrence of oral Candida colonization and its risk factors among patients with malignancies in China. Clin Oral Investig. 2016;20(3):459–467. doi:10.1007/s00784-015-1524-2
   Web of Science ®Google Scholar
• Mohammadi R, Ataei B. Candidiasis in pediatrics; identification and in vitro antifungal susceptibility of the clinical isolates. Iran J Ped Hematol Oncol. 2016;6(1):43–51.27222702
   PubMedGoogle Scholar
• Jayachandran AL, Katragadda R, Thyagarajan R, et al. Oral candidiasis among cancer patients attending a Tertiary Care hospital in Chennai, South India: an evaluation of clinicomycological association and antifungal susceptibility pattern. Can J Infect Dis Med Microbiol. 2016;2016:8758461. doi:10.1155/2016/875846127403171
   PubMed Web of Science ®Google Scholar
• Berberi A, Noujeim Z, Aoun G. Epidemiology of oropharyngeal candidiasis in human immunodeficiency virus/acquired immune deficiency syndrome patients and CD4+ counts. J Int Oral Health. 2015;7(3):20–23.
   PubMedGoogle Scholar
• Silva-Rocha WP, de Brito Lemos VL, Ferreira MR, et al. Effect of the crude extract of Eugenia uniflora in morphogenesis and secretion of hydrolytic enzymes in Candida albicans from the oral cavity of kidney transplant recipients. BMC Complement Altern Med. 2015;15:6. doi:10.1186/s12906-015-0522-x25651849
   PubMed Web of Science ®Google Scholar
• Minea B, Nastasa V, Kolecka A, et al. Etiologic agents and antifungal susceptibility of oral candidosis from Romanian patients with HIV-infection or type 1 diabetes mellitus. Pol J Microbiol. 2016;65(1):123–129.27282005
   PubMed Web of Science ®Google Scholar
• Das PP, Saikia L, Nath R, Phukan SK. Species distribution & antifungal susceptibility pattern of oropharyngeal Candida isolates from human immunodeficiency virus infected individuals. Indian J Med Res. 2016;143(4):495–501. doi:10.4103/0971-5916.18428827377507
   PubMed Web of Science ®Google Scholar
• Clark-Ordonez I, Callejas-Negrete OA, Arechiga-Carvajal ET, Mourino-Perez RR. Candida species diversity and antifungal susceptibility patterns in oral samples of HIV/AIDS patients in Baja California, Mexico. Med Mycol. 2016. doi:10.1093/mmy/myw069
   Web of Science ®Google Scholar
• Wu J, Guo H, Yi G, et al. Prevalent drug resistance among oral yeasts from asymptomatic patients in Hainan, China. Mycopathologia. 2014;177(5–6):299–307. doi:10.1007/s11046-014-9747-324816793
   PubMed Web of Science ®Google Scholar
• Geusau A, Antoniewicz L, Poitschek C, Presterl E, Willinger B. In vitro susceptibility of Candida isolates from organ transplant recipients to newer antifungals. Mycopathologia. 2014;177(3–4):143–156. doi:10.1007/s11046-014-9738-424682600
   PubMed Web of Science ®Google Scholar
• Zhang LW, Fu JY, Hua H, Yan ZM. Efficacy and safety of miconazole for oral candidiasis: a systematic review and meta-analysis. Oral Dis. 2016;22(3):185–195. doi:10.1111/odi.1238026456226
   PubMed Web of Science ®Google Scholar
• Marcos-Arias C, Eraso E, Madariaga L, Carrillo-Munoz AJ, Quindos G. In vitro activities of new triazole antifungal agents, posaconazole and voriconazole, against oral Candida isolates from patients suffering from denture stomatitis. Mycopathologia. 2012;173(1):35–46. doi:10.1007/s11046-011-9460-421842426
   PubMed Web of Science ®Google Scholar
• Li YY, Chen WY, Li X, et al. Asymptomatic oral yeast carriage and antifungal susceptibility profile of HIV-infected patients in Kunming, Yunnan Province of China. BMC Infect Dis. 2013;13:46. doi:10.1186/1471-2334-13-4623356471
   PubMed Web of Science ®Google Scholar
• Garcia-Cuesta C, Sarrion-Perez MG, Bagan JV. Current treatment of oral candidiasis: a literature review. J Clin Exp Dent. 2014;6(5):e576–e582. doi:10.4317/jced.5179825674329
   PubMedGoogle Scholar
• Wang H, Fan YY, Kudinha T, et al. A comprehensive evaluation of the Bruker Biotyper MS and Vitek MS Matrix-Assisted laser desorption ionization-time of flight mass spectrometry systems for identification of yeasts, part of the National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study, 2012 to 2013. J Clin Microbiol. 2016;54(5):1376–1380. doi:10.1128/JCM.00162-1626912761
   PubMed Web of Science ®Google Scholar
• Zhang L, Xiao M, Wang H, et al. Yeast identification algorithm based on use of the Vitek MS system selectively supplemented with ribosomal DNA sequencing: proposal of a reference assay for invasive fungal surveillance programs in China. J Clin Microbiol. 2014;52(2):572–577. doi:10.1128/JCM.02543-1324478490
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard M27-A3. 3rd ed[S] Wayne, PA: Clinical and Laboratory Standards Institute; 2007.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antifungal Susceptibility Testing of Yeasts. 1st ed[S] Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
   Google Scholar
• Clinical and Laboratory Standards Institute. Epidemiological Cutoff Values for Antifungal Susceptibility Testing. 2nd ed[S] Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
   Google Scholar
• Pfaller MA, Diekema DJ. Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and laboratory standards institute broth microdilution methods, 2010 to 2012. J Clin Microbiol. 2012;50(9):2846–2856. doi:10.1128/JCM.00937-1222740712
   PubMed Web of Science ®Google Scholar
• Blanco D, van Rossem K. A prospective two-year assessment of miconazole resistance in Candida spp. With repeated treatment with 0.25% miconazole nitrate ointment in neonates and infants with moderate to severe diaper dermatitis complicated by cutaneous candidiasis. Pediatr Dermatol. 2013;30(6):717–724. doi:10.1111/pde.1210723675632
   PubMed Web of Science ®Google Scholar
• Paula SB, Morey AT, Santos JP, et al. Oral Candida colonization in HIV-infected patients in Londrina-PR, Brazil: antifungal susceptibility and virulence factors. J Infect Dev Ctries. 2015;9(12):1350–1359. doi:10.3855/jidc.697026719941
   PubMed Web of Science ®Google Scholar
• Razzaghi-Abyaneh M, Sadeghi G, Zeinali E, et al. Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran. J Mycol Med. 2014;24(2):e43–e50. doi:10.1016/j.mycmed.2014.01.00424767256
   PubMedGoogle Scholar
• Kuriyama T, Williams DW, Bagg J, Coulter WA, Ready D, Lewis MA. In vitro susceptibility of oral Candida to seven antifungal agents. Oral Microbiol Immunol. 2005;20(6):349–353. doi:10.1111/j.1399-302X.2005.00236.x16238594
   PubMedGoogle Scholar
• Hamza OJ, Matee MI, Moshi MJ, et al. Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis. BMC Microbiol. 2008;8:135. doi:10.1186/1471-2180-8-13518694525
   PubMed Web of Science ®Google Scholar
• Xiao M, Sun ZY, Kang M, et al. Five-year national surveillance of invasive Candidiasis: species distribution and Azole susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study. J Clin Microbiol. 2018;56(7). doi:10.1128/JCM.00577-18.
   Web of Science ®Google Scholar
• Guo LN, Xiao M, Cao B, et al. Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections across urban Beijing, China. Future Microbiol. 2017;12:1075–1086. doi:10.2217/fmb-2017-003628836465
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Gibbs DL, et al. Results from the ARTEMIS DISK global antifungal surveillance study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol. 2010;48(4):1366–1377. doi:10.1128/JCM.02117-0920164282
   PubMed Web of Science ®Google Scholar
• Kamikawa Y, Mori Y, Nagayama T, et al. Frequency of clinically isolated strains of oral Candida species at Kagoshima University Hospital, Japan, and their susceptibility to antifungal drugs in 2006-2007 and 2012-2013. BMC Oral Health. 2014;14:14. doi:10.1186/1472-6831-14-9024552136
   PubMed Web of Science ®Google Scholar
• Stefaniuk E, Baraniak A, Fortuna M, Hryniewicz W. Usefulness of CHROMagar Candida Medium, Biochemical Methods–API ID32C and VITEK 2 compact and two MALDI-TOF MS systems for Candida spp. identification. Pol J Microbiol. 2016;65(1):111–114.27282002
   PubMed Web of Science ®Google Scholar
• Chao QT, Lee TF, Teng SH, et al. Comparison of the accuracy of two conventional phenotypic methods and two MALDI-TOF MS systems with that of DNA sequencing analysis for correctly identifying clinically encountered yeasts. PLoS One. 2014;9(10):e109376. doi:10.1371/journal.pone.010937625330370
   PubMed Web of Science ®Google Scholar
• Goldman M, Cloud GA, Smedema M, et al. Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection? Antimicrob Agents Chemother. 2000;44(6):1585–1587.10817713
   PubMed Web of Science ®Google Scholar
• Lortholary O, Petrikkos G, Akova M, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS. Clin Microbiol Infect. 2012;18(Suppl 7):68–77. doi:10.1111/1469-0691.1204223137138
   PubMed Web of Science ®Google Scholar
• Cartledge JD, Midgley J, Petrou M, Shanson D, Gazzard BG. Unresponsive HIV-related oro-oesophageal candidosis – an evaluation of two new in-vitro azole susceptibility tests. J Antimicrob Chemother. 1997;40(4):517–523.9372421
   PubMed Web of Science ®Google Scholar